24 October 2023 - Thousands of patients in England and Northern Ireland are missing out on a life-extending prostate cancer drug that is more widely available on the NHS in Scotland and Wales, say experts.
Charity Prostate Cancer UK said it was "unacceptable" that men in parts of the UK were facing a postcode lottery.